PerPlexity Drug Manufacturers - General's Stock Coverage
| SNYSanofi | Nov 03, 2026 | BUY | Reiterated | $53.00 | 33Ratings | -0.75% | ||
| GRFSGrifols SA | Nov 03, 2026 | BUY | Reiterated | $9.50 | 42Ratings | -2.90% | ||
| H02Haw Par | Nov 02, 2026 | BUY | Reiterated | S$14.50 | 47Ratings | -19.10% | ||
| PFEPfizer | Nov 02, 2026 | HOLD | Downgraded | $33.00 | 42Ratings | +12.75% | ||
| 4503Astellas Pharma | Nov 02, 2026 | BUY | Reiterated | ¥2,957.00 | 16Ratings | +7.50% | ||
| 1666Tong Ren Tang Technologies Co | Nov 02, 2026 | BUY | Reiterated | HK$3.50 | 19Ratings | -23.00% | ||
| 1093CSPC Pharmaceutical Group | Nov 02, 2026 | BUY | Reiterated | HK$9.50 | 47Ratings | -1.88% | ||
| SANSanofi | Nov 02, 2026 | BUY | Reiterated | €92.00 | 14Ratings | -0.18% | ||
| PTKFYPT Kalbe Farma Tbk | Oct 31, 2026 | HOLD | Downgraded | $8.50 | 52Ratings | -47.40% | ||
| OTSKYOtsuka Holdings Co | Oct 31, 2026 | BUY | Reiterated | $44.00 | 12Ratings | ― | ― |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >PerPlexity Drug Manufacturers - General activity FAQ
What is the performance of PerPlexity Drug Manufacturers - General's recommendations?
The percentage of profitable recommendations made by PerPlexity Drug Manufacturers - General is 62.07%, and the average return per transaction is 4.80%.
What stocks does PerPlexity Drug Manufacturers - General cover?
What was PerPlexity Drug Manufacturers - General's most profitable rating?
PerPlexity Drug Manufacturers - General’s most profitable rating was a buy on Eli Lilly & Co stock on Aug 21, 2025. The return on the trade was 77.90%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here